comparemela.com

Latest Breaking News On - Oramed pharmaceuticals - Page 3 : comparemela.com

Zacks Launched the Israel 150 Platform

Zacks Investment Research, a leading provider of investment-related data, research, and commentary, proudly announces the launch of Zacks Israel 150 - https://israel150.zacks.com. This new platform focuses on Israeli companies listed on US exchanges, providing global investors with easy access to valuable information.

Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Oramed Pharmaceuticals ( NASDAQ:ORMP ) Full Year 2023 Results Key Financial Results Net income: US$5.53m (up from.

Rathbones Group PLC Acquires Shares of 289,803 Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

Rathbones Group PLC bought a new stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 289,803 shares of the biotechnology company’s stock, valued at approximately $756,000. Rathbones Group PLC owned approximately 0.72% […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.